⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15887093 | 1.00 | — | — | |
| SCHEMBL9899984 | 1.00 | — | — | |
| SCHEMBL15887094 | 1.00 | — | — | |
| SCHEMBL19371148 | 1.00 | — | — | |
| SCHEMBL20200287 | 1.00 | — | — | |
| SCHEMBL24831717 | 1.00 | — | — | |
| SCHEMBL20276680 | 0.82 | CCR5 (0.32) | — | |
| SCHEMBL1427994 | 0.78 | — | — | |
| SCHEMBL89457 | 0.78 | — | — | |
| SCHEMBL5381064 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007684-A1 | AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | VENTUS THERAPEUTICS U S INC (US) | 2026-01-08 | — | — | US | disclosed |
| CN-112094224-B | Preparation method of 3-substituted-5-aminopiperidine with protecting group | 浙江医药股份有限公司新昌制药厂 | 2022-08-26 | — | — | CN | disclosed |
| CN-112094224-A | Preparation method of 3-substituted-5-aminopiperidine with protecting group | 太景生物科技股份有限公司 | 2020-12-18 | — | — | CN | disclosed |
| WO-2020099882-A1 | HETEROCYCLIC SPIRO-COMPOUNDS AS AM2 RECEPTOR INHIBITORS | THE UNIVERSITY OF SHEFFIELD (GB) | 2020-05-22 | — | — | WO | disclosed |
| US-8158798-B2 | Coupling process for preparing quinolone intermediates | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2012-04-17 | — | — | US | disclosed |
| WO-2010002415-A1 | TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA INFECTION | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-01-07 | — | — | WO | disclosed |
| WO-2010002965-A2 | PNEUMONIA TREATMENT | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-01-07 | — | — | WO | disclosed |
| US-20090111991-A1 | Coupling Process For Preparing Quinolone Intermediates | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) | 2009-04-30 | — | — | US | disclosed |
| WO-2009023473-A2 | ANTIMICROBIAL PARENTERAL FORMULATION | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2009-02-19 | — | — | WO | disclosed |
| EP-1999125-A2 | A COUPLING PROCESS FOR PREPARING QUINOLONE INTERMEDIATES | The Procter and Gamble Company (US) | 2008-12-10 | — | — | EP | disclosed |
| US-7456279-B2 | Coupling process for preparing quinolone intermediates | THE PROCTER & GAMBLE COMPANY (US) | 2008-11-25 | — | — | US | disclosed |
| US-20070232804-A1 | Coupling process for preparing quinolone intermediates | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-04 | — | — | US | disclosed |
| WO-2007110835-A2 | A COUPLING PROCESS FOR PREPARING QUINOLONE INTERMEDIATES | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-04 | — | — | WO | disclosed |